Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Obstructive sleep apnea is the most common sleep related beathing disorder and it is characterised by recurrent episodes of complete or partial obstruction of the upper airway leading to reduced or absent breathing at the time of sleep. These episodes are termed as apneas with complete or near-complete termination of breathing or hypopneas when the reduction in breathing is partial. In either case, a fall in blood oxygen saturation, a disruption in sleep or both may result. A high frequency of apneas or hypopneas during sleep may interfere with restorative sleep which in combination with disturbances in blood oxygenation is thought to contribute to negative consequences to healthy and quality of life.
The obstructive sleep apnea (OSA) market is anticipated to grow at CAGR of 6.10% during forecast period of 2022-2028. The large pool of undiagnosed sleep apnea patients is propelling growth of obstructive sleep apnea market. Also, growing awareness among patients is also boosting growth of obstructive sleep apnea market. Increase in geriatric population is also refuelling growth of obstructive sleep apnea market. However, high cost of CPAP machines is likely to hinder the growth of obstructive sleep apnea market.
The exclusive COVID-19 impact analysis report by axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the obstructive sleep apnea market. In addition, complete analysis of changes on the obstructive sleep apnea expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices.
The obstructive sleep apnea market is segmented into type, end user and geography.
The various type of sleep apnea devices such as airway clearance system, adaptive servo-ventilation, positive airway pressure device, oral appliances and oxygen devices are comprised in the obstructive sleep apnea market. In which positive airway pressure devices is estimated to dominate the market in 2020. The positive airway pressure therapy is a common treatment for obstructive sleep apnea. A CPAP machines uses a hose and mask or nosepiece for delivering constant and steady air pressure. The CPAP devices also helps in prevention of heart diseases, stroke, diabetes and improves the daytime alertness.
The various end users such as hospital and sleep laboratories and home care settings are comprised in the obstructive sleep apnea market. In which home care settings is likely to dominate the market in 2020. The growing preference towards homecare is propelling growth of obstructive sleep apnea market. The rising need for reducing healthcare costs is also boosting growth of obstructive sleep apnea market. The growing awareness among patients is also driving growth of obstructive sleep apnea market.
The obstructive sleep apnea market is studied for key countries of regions such as North America, Europe, Asia Pacific and Rest of the World. The North America is anticipated to dominate the market in 2020. The growing presence of key players is propelling growth of obstructive sleep apnea market. The growing pool of undiagnosed sleep apnea patients is also boosting growth of obstructive sleep apnea market. The rising healthcare expenditure is also driving growth of obstructive sleep apnea market.
The major key players of the markets are Becton Dickinson (CareFusion Corporation), BMC Medical Co. Ltd, Braebon Medical Corporation, Cadwell Laboratories Inc., Compumedics Limited, Curative Medical Inc, Fisher & Paykel Healthcare, GE Healthcare, ImThera, Invacare Corporation, Koninklijke Philips N.V., LivaNova, Nidek Medical India, Inspire Medical System, Somnomed, Oventus Medical and Drive Devilbiss Healthcare among others.
February 2021: The Cadwell acquired Sleepmate sleep diagnostic sensors from Ambu A/S. The Sleepmate products have been providing high quality and reliable sleep diagnostic sensor solutions for more than 30 years. Cadwell is now honoured to comprise Sleepmate portfolio as an integral part of its comprehensive sleep diagnostic solutions for both in-lab and at home testing.
August 2021: ResMed had launched their new positive airway pressure device in the US to help hundreds of millions of people with sleep apnea.
September 2020: ResMed launched first CPAP Nasal Mask with memory foam. The company recently launched their first continuos positive airway pressure (CPAP) nasal mask with a memory foam cushion, the AirTouch N20. As per the company it is the softest nasal mask till date.
October 2019: ResMed Launched AirFit N30 mask, a tube-down nasal cradle CPAP mask with a front tub which is a new option for sleep apnea treatment. ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, a nasal cradle cushion which sits under nasal bridge, eliminating soreness in those areas. The masks curved cushion is designed for supplying a secured seal regardless of how the wearer sleeps or moves.
The report analyses obstructive sleep apnea (OSA) market based on type, end user and geography. By type, the market is segmented into the airway clearance system, adaptive servo-ventilation, positive airway pressure device, oral appliances and oxygen devices. Based on end user, the market is bifurcated into homecare settings and hospital and sleep laboratories. The report also analyses the impact of COVID-19 on the market and it analysed that The market witnessed the growth during owing to sudden outbreak of the COVID-19 pandemic. In first quarter of 2020, companies faced some operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and adverse impact of the virus on sleep apnea patients leads to rise in the demand and production of sleep apnea devices. The report also comprised of major key players operating in the market.
Why to buy this report:
